BREAKING NEWS

EU recommends suspending hundreds of drugs tested by Indian firm

By REUTERS

MARCH 25, 2017 12:29

Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs.

The decision, announced by the European Medicines Agency (EMA) on its website, is the latest blow for India's drug-testing industry, which has run into a series of problems with international regulators in recent years.

Nobody at the Chennai-based company was immediately available to comment.

The EMA said European officials had been investigating Micro Therapeutic's compliance with good clinical practice after Austrian and Dutch authorities raised concerns in February 2016.

IDF, Hezbollah exchange fire on Lebanon border

By JERUSALEM POST STAFF

04/26/2024 01:22 AM

Bernie Sanders to Netanyahu: you are using antisemitism as a distraction

By JERUSALEM POST STAFF

04/26/2024 12:33 AM

Yeshiva University re-opens admissions amid safety concerns on campuses

By JERUSALEM POST STAFF

04/26/2024 12:19 AM

US preparing to announce $6b in weapons for Ukraine, Politico reports

By REUTERS

04/26/2024 12:12 AM